Editorial: Towards individualised treatment in COPD

Thorax

Volumn 66, Issue 5, 2011, Pages 363-364

  Fingleton, James ^a   Weatherall, Mark ^b   Beasley, Richard ^a  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL GAS; ASTHMA; ATOPY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EDITORIAL; ENVIRONMENTAL FACTOR; EXERCISE TOLERANCE; FACTORIAL ANALYSIS; HISTORY; HUMAN; HYPERINFLATION; INFLAMMATION; INFORMATION PROCESSING; LUNG EMPHYSEMA; LUNG FUNCTION; NUTRITIONAL STATUS; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PHENOTYPE; PRACTICE GUIDELINE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SMOKING; SYMPTOM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT RESPONSE; CLASSIFICATION; METHODOLOGY; NOTE;

CLUSTER ANALYSIS; HUMANS; INDIVIDUALIZED MEDICINE; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79954992060     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.155564     Document Type: Editorial

References (25)

1. Briscoe WA, Nash ES. The slow space in chronic obstructive pulmonary diseases. Ann NY Acad Sci 1965;121:706-22.
2. Travers J, Marsh S, Caldwell B, et al. External validity of randomized controlled trials in COPD. Respir Med 2007;101:1313-20. (Pubitemid 46667661)
3. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987;317:1309-14. (Pubitemid 17153012)
4. Snider GL. Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Am Rev Respir Dis 1989;140: S3-8. (Pubitemid 19231329)
5. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152: S77-121.
6. Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax 2008;63:761-7.
7. Wegner RE, Jorres RA, Kirsten DK, et al. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994;7:725-9. (Pubitemid 24122970)
8. Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:467-70.
9. Lapperre TS, Snoeck-Stroband JB, Gosman MM, et al. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:499-504. (Pubitemid 39209130)
10. Ries AL, Kaplan RM, Blumberg E. Use of factor analysis to consolidate multiple outcome measures in chronic obstructive pulmonary disease. J Clin Epidemiol 1991;44:497-503.
11. Roy K, Smith J, Kolsum U, et al. COPD phenotype description using principal components analysis. Respir Res 2009;10:41.
12. Fuchs-Climent D, Le Gallais D, Varray A, et al. Factor analysis of quality of life, dyspnea, and physiologic variables in patients with chronic obstructive pulmonary disease before and after rehabilitation. Am J Phys Med Rehabil 2001;80:113-20. (Pubitemid 32121613)
13. Weatherall M, Shirtcliffe P, Travers J, et al. Use of cluster analysis to define COPD phenotypes. Eur Respir J 2010;36:472-4.
14. Garcia-Aymerich J, Gomez FP, Benet M, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011;66:430-37.
15. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370:797-9. (Pubitemid 47320803)
16. Weatherall M, Travers J, Shirtcliffe PM, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009;34:812-18.
17. Wardlaw AJ, Silverman M, Siva R, et al. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005;35:1254-62.
18. Burgel PR, Paillasseur JL, Caillaud D, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010;36:531-9.
19. Pistolesi M, Camiciottoli G, Paoletti M, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med 2008;102:367-76.
20. Cho MH, Washko GR, Hoffmann TJ, et al. Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respir Res 2010;11:30.
21. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-52. (Pubitemid 35178607)
22. Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med 2007;101:1305-12. (Pubitemid 46667662)
23. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
24. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182:598-604.
25. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010;181:315-23.